Saccharomyces boulardii CNCM I-745

Saccharomyces boulardii CNCM I-745 is a probiotic yeast that produces bioactive compounds like polyamines and proteases to restore gut microbiota balance. It prevents diarrhea by inhibiting pathogenic bacteria adhesion and strengthening intestinal barrier function through enhanced tight junction proteins.

Origin & History

Saccharomyces boulardii CNCM I-745 is a probiotic yeast isolated from tropical fruits. It is produced through fermentation and is commonly used in dietary supplements.

Historical & Cultural Context

Discovered in the 1920s, Saccharomyces boulardii has been used for its probiotic benefits for nearly a century, particularly in managing digestive disorders.

Health Benefits

- Supports digestive health by balancing the gut microbiota, helping to restore beneficial bacteria after antibiotic use. - May prevent and treat various types of diarrhea, including antibiotic-associated and traveler’s diarrhea, by inhibiting pathogenic microbes. - Strengthens intestinal barrier function, reducing gut permeability and supporting nutrient absorption. - Modulates immune responses, lowering inflammation and enhancing resistance to infections. - Reduces symptoms of irritable bowel syndrome (IBS), such as bloating and discomfort, by regulating gut motility. - Produces short-chain fatty acids that nourish colon cells and improve overall gut health. - May decrease the duration of acute diarrhea in children by up to 24 hours, according to clinical studies. - Aids in the breakdown of dietary fiber, supporting regular bowel movements and digestive comfort.

How It Works

Saccharomyces boulardii produces proteases that degrade bacterial toxins and releases polyamines that enhance intestinal epithelial cell proliferation. It competitively inhibits pathogenic bacteria adhesion to intestinal mucosa by binding to common receptor sites. The yeast stimulates secretory IgA production and increases expression of tight junction proteins like claudin-1 and occludin to strengthen intestinal barrier integrity.

Scientific Research

Saccharomyces boulardii CNCM I-745 has been extensively studied, with numerous RCTs demonstrating its efficacy in preventing and treating diarrhea. Meta-analyses confirm its benefits in various gastrointestinal conditions.

Clinical Summary

Multiple randomized controlled trials with 50-400 participants demonstrate Saccharomyces boulardii CNCM I-745 reduces antibiotic-associated diarrhea incidence by 57-70% when taken at 250-500mg twice daily. Meta-analyses of 31 studies show significant efficacy in preventing Clostridium difficile-associated diarrhea with NNT of 12.5. Studies in traveler's diarrhea show 40-50% reduction in symptom duration and severity. Evidence quality is considered moderate to high for diarrhea prevention, with most studies showing consistent beneficial outcomes across diverse populations.

Nutritional Profile

- Contains live probiotic yeast cultures. - Produces bioactive compounds that support gut health. - Rich in enzymes that aid digestion.

Preparation & Dosage

Typical dosage ranges from 250 to 500 mg per day. Consult a healthcare provider before use.

Synergy & Pairings

Prebiotic Fiber,L-Glutamine,Zinc

Safety & Interactions

Saccharomyces boulardii is generally well-tolerated with mild side effects including bloating, gas, and constipation in less than 5% of users. Rare cases of fungemia have been reported in severely immunocompromised patients or those with central venous catheters. The yeast may reduce absorption of certain antifungal medications like fluconazole and should be separated by 2-3 hours. Safety during pregnancy and breastfeeding has not been established, though no adverse effects have been reported in limited studies.